Newsletter
Join the Community
Subscribe to our newsletter for the latest news and updates
A sequencing company pushing instrument competition in genomics with a focus on throughput, flexibility, and platform economics.
Platform purchase with operational and service planning required.
Element Biosciences builds sequencing systems for research teams that want another serious option in high-throughput genomics.
It matters because platform competition in sequencing changes both buying decisions and editorial search intent.
